Skip to main content

Table 1 Correlation between SNHG16 expression and neuroblastoma clinicopathological parameters

From: SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells

Parameters n SNHG16 P
High(n = 38) Low(n = 38)
Age(years)
 < 5 52 28 24 0.324
 ≥ 5 24 10 14  
Gender
 Female 40 19 21 0.646
 Male 36 19 17  
INSS staging
 1–2 41 13 28 0.011*
 3–4 29 20 9  
 4 s 6 5 1  
Tumor size (cm)
 ≥ 7 28 16 22 0.054
 < 7 48 22 26  
Metastasis
 Yes 25 17 8 0.028*
 No 51 21 30  
Median survival time (months)   32.05 ± 8.54 38.6 ± 9.86 0.003*
  1. Note: *P < 0.05